Suchergebnisse - "Perrone, Francesco"

PubPharm (33)

1

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2023

von Chu, Q. | Perrone, F. | Greillier, L. | +32

CommentIn: Lancet. 2023 Dec 16;402(10419):2266-2267. - PMID 37931626

2

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC : The BEVERLY Multicenter Randomized Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Piccirillo, M. | Bonanno, L. | Garassino, M. | +30

3

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Pignata, S. | Lorusso, D. | Joly, F. | +62

4

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer : HOBOE phase 3 randomised trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Perrone, F. | De Laurentiis, M. | De Placido, S. | +29

CommentIn: Eur J Cancer. 2019 Sep;118:166-168. - PMID 31374402

5

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

enthalten in: Gynecologic oncology | 2019

von Daniele, G. | Arenare, L. | Scambia, G. | +25

6

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer : Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Morabito, A. | Piccirillo, M. | Maione, P. | +27

7

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer : Joint Analysis of MILES-3 and MILES-4 Phase III Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Gridelli, C. | Morabito, A. | Cavanna, L. | +27

CommentIn: J Clin Oncol. 2018 Sep 1;36(25):2571-2574. - PMID 30028655

8

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3) : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von De Placido, S. | Gallo, C. | De Laurentiis, M. | +128

CommentIn: Lancet Oncol. 2018 Apr;19(4):431-432. - PMID 29482984

9

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer : The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Pignata, S. | Scambia, G. | Bologna, A. | +25

10

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients : The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2017

von Morabito, A. | Daniele, G. | Costanzo, R. | +17